ACCC publishes white paper on integrated health care systems

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE ASSOCIATION OF COMMUNITY CANCER CENTERS published a white paper, titled “What Will It Take? Five Essential Actions to Achieve a Positive Impact on Patient Care in the Integrated Healthcare Environment,” at its 32nd National Oncology Conference, addressing patient care in a changing provider setting.

The five actions described in the white paper are: aligning stakeholders and requiring accountability; defining quality in a value-based reimbursement system and providing access to quality care; using non-traditional delivery systems such as telehealth and primary care physicians and non-physician providers to deliver cancer care; integrating the use of big data to drive treatment decisions; and moving to patientdirected care in which the patient is at the center of all decisions and systemic change.

“Increased integration will impact all aspects of an organization’s cancer care delivery — cultural, operational, clinical and financial,” said ACCC President Steven D’Amato. “Our focus in this newly integrated environment is to provide education for hospital systems and physician practices on how to offer the best collaborative oncology care in a seamless way for patients.”

YOU MAY BE INTERESTED IN

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login